Staphylococcus aureus DSM 105272 is a human pathogen of the family Staphylococcaceae.
human pathogen Bacteria| @ref 20215 |
Last LPSN update
2026-02-09 11:33:26 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 42429 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive  | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 42429 | positive | growth | 37 |
| @ref | Pathogenicity human | Pathogenicity animal | Biosafety level | Biosafety level comment | |
|---|---|---|---|---|---|
| 42429 | 2 | Risk group (German classification) |
Phages| @ref | Name | Strain number | |
|---|---|---|---|
| 124042 | Staphylococcus phage vB_SauS_CS1 | DSM 105272 | |
| 124042 | Staphylococcus phage Phi DW2 | DSM 105272 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Statistical Optimization of Bacterial Cellulose Production and Its Application for Bacteriophage Immobilization. | Skaradzinski G, Janek T, Sliwka P, Skaradzinska A, Laba W. | Int J Mol Sci | 10.3390/ijms26136059 | 2025 |  | |
| Computational Pipeline for Targeted Integration and Variable Payload Expression in Bacteriophage Engineering. | Fernbach J, Hegedis E, Loessner MJ, Kilcher S. | ACS Synth Biol | 10.1021/acssynbio.5c00450 | 2025 | | |
| Enhancing the antimicrobial activity of silver nanoparticles against ESKAPE bacteria and emerging fungal pathogens by using tea extracts. | Raza S, Wdowiak M, Grotek M, Adamkiewicz W, Nikiforow K, Mente P, Paczesny J. | Nanoscale Adv | 10.1039/d3na00220a | 2023 | | |
| Protecting bacteriophages under UV irradiation with brilliant blue FCF for targeted bacterial control | Wdowiak M, Magiera A, Tomczynska M, Adamkiewicz W, Stellacci F, Paczesny J. | Biofilm | 2025 | | ||
| First Molecular Characterization of Siphoviridae-Like Bacteriophages Infecting Staphylococcus hyicus in a Case of Exudative Epidermitis. | Tetens J, Sprotte S, Thimm G, Wagner N, Brinks E, Neve H, Holzel CS, Franz CMAP. | Front Microbiol | 10.3389/fmicb.2021.653501 | 2021 | | |
| Metabolism | Assessment of the bacteriocinogenic potential of marine bacteria reveals lichenicidin production by seaweed-derived Bacillus spp. | Prieto ML, O'Sullivan L, Tan SP, McLoughlin P, Hughes H, O'Connor PM, Cotter PD, Lawlor PG, Gardiner GE. | Mar Drugs | 10.3390/md10102280 | 2012 | |
| Genetics | Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. | O'Flaherty S, Coffey A, Edwards R, Meaney W, Fitzgerald GF, Ross RP. | J Bacteriol | 10.1128/jb.186.9.2862-2871.2004 | 2004 | |
| Metabolism | The potency of the broad spectrum bacteriocin, bactofencin A, against staphylococci is highly dependent on primary structure, N-terminal charge and disulphide formation. | O' Connor PM, O' Shea EF, Cotter PD, Hill C, Ross RP | Sci Rep | 10.1038/s41598-018-30271-6 | 2018 | |
| Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase. | Keary R, McAuliffe O, Ross RP, Hill C, O'Mahony J, Coffey A | Bacteriophage | 10.4161/bact.28451 | 2014 | | |
| Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms. | Fenton M, Keary R, McAuliffe O, Ross RP, O'Mahony J, Coffey A | Int J Microbiol | 10.1155/2013/625341 | 2013 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive139821.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License